Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Market Cap	1.10T
Revenue (ttm)	521.50B
Net Income (ttm)	62.57B
Shares Out	9.33M
EPS (ttm)	6,704.93
PE Ratio	17.51
Forward PE	n/a
Dividend	2,400.00 (2.04%)
Ex-Dividend Date	Sep 9, 2025

Volume	2,462
Average Volume	3,824
Open	134,500
Previous Close	130,400
Day's Range	117,400 - 143,400
52-Week Range	96,000 - 143,400
Beta	-0.30
RSI	54.41
Earnings Date	Jan 19, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also pro...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 535
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PMC

Financial Performance

In 2024, HNX:PMC's revenue was 498.18 billion, an increase of 2.68% compared to the previous year's 485.19 billion. Earnings were 58.50 billion, a decrease of -4.11%.